CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Revvity Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Revvity Inc
77 4Th Avenue
Phone: (781) 663-6900p:781 663-6900 WALTHAM, MA  02451  United States Ticker: RVTYRVTY
Business Summary
Revvity, Inc. is a provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. The Company has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-YesYesYes-

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/29/202412/29/2024YesYes--Yes

Industries
SIC Code Description
3826 Laboratory analytical instruments
3845 Electromedical and electrotherapeutic apparatus
3829 Measuring and controlling devices, not elsewhere classified
3841 Surgical and medical instruments and apparatus
8734 Testing laboratories
7371 Computer programming services
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Non-Executive Chairman of the Board Alexandros P.Michas 67 12/30/2019 1/1/2001
President, Chief Executive Officer, Director Prahlad R.Singh 60 12/30/2019 9/1/2016
Chief Financial Officer, Senior Vice President MaxwellKrakowiak 35 9/6/2022 9/6/2022
8 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
IMMUNODIAGNOSTIC SYSTEMS LIMITED 10 DIDCOT WAY BOLDON BUSINESS PARK UK
PERKINELMER LAS (UK) LIMITED CHALFONT ROAD SEER GREEN UK
SOLUS SCIENTIFIC SOLUTIONS LIMITED TORUS BUILDING RANKINE AVENUE SCOTTISH ENTERPRISE TECHNOLOGY UK
39 additional Subsidiary records available in full report.

Business Names
Business Name
2Cure, LLC
Beijing OUMENG Biotechnology Co., Ltd.
Bio Evolution SAS
169 additional Business Names available in full report.

General Information
Number of Employees: 11,000 (As of 12/29/2024)
Outstanding Shares: 120,147,286 (As of 2/25/2025)
Shareholders: 2,753
Stock Exchange: NYSE
Federal Tax Id: 042052042


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, March 29, 2025